- Home
- PPBT vs BON Comparison
PPBT vs BON Comparison
Compare PPBT & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- BON
- Stock Information
- Founded
- PPBT 2010
- BON 2006
- Country
- PPBT Israel
- BON China
- Employees
- PPBT N/A
- BON N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- BON Medicinal Chemicals and Botanical Products
- Sector
- PPBT Health Care
- BON Health Care
- Exchange
- PPBT Nasdaq
- BON Nasdaq
- Market Cap
- PPBT 6.2M
- BON 5.9M
- IPO Year
- PPBT N/A
- BON 2021
- Fundamental
- Price
- PPBT $2.08
- BON $1.32
- Analyst Decision
- PPBT Strong Buy
- BON
- Analyst Count
- PPBT 1
- BON 0
- Target Price
- PPBT $33.00
- BON N/A
- AVG Volume (30 Days)
- PPBT 258.8K
- BON 1.3M
- Earning Date
- PPBT 08-15-2025
- BON 08-05-2025
- Dividend Yield
- PPBT N/A
- BON N/A
- EPS Growth
- PPBT N/A
- BON N/A
- EPS
- PPBT N/A
- BON 4.17
- Revenue
- PPBT N/A
- BON $23,844,556.00
- Revenue This Year
- PPBT N/A
- BON $223.38
- Revenue Next Year
- PPBT N/A
- BON $18.82
- P/E Ratio
- PPBT N/A
- BON $0.31
- Revenue Growth
- PPBT N/A
- BON N/A
- 52 Week Low
- PPBT $2.00
- BON $1.14
- 52 Week High
- PPBT $13.95
- BON $73.75
- Technical
- Relative Strength Index (RSI)
- PPBT 32.49
- BON 40.79
- Support Level
- PPBT $2.35
- BON $1.41
- Resistance Level
- PPBT $2.90
- BON $1.46
- Average True Range (ATR)
- PPBT 0.17
- BON 0.08
- MACD
- PPBT -0.06
- BON 0.00
- Stochastic Oscillator
- PPBT 1.20
- BON 7.41
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About BON Bon Natural Life Limited
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.